英科医疗涨5.80%，中邮证券一个月前给出“买入”评级

Core Viewpoint - The report by Zhongyou Securities indicates that the price of nitrile gloves is expected to bottom out soon, and the overseas production base of Yingke Medical is anticipated to commence production by the end of the year, leading to a "buy" rating for the stock [1] Financial Summary - Yingke Medical's Q1 2025 report shows a main revenue of 2.494 billion yuan, a year-on-year increase of 13.2% - The net profit attributable to the parent company is 353 million yuan, reflecting a year-on-year increase of 48.08% - The net profit after deducting non-recurring items is 247 million yuan, up 53.2% year-on-year - The company's debt ratio stands at 51.61%, with investment income of 24.27 million yuan and financial expenses of -12.18 million yuan - The gross profit margin is reported at 24.16% [1] Institutional Ratings - In the last 90 days, four institutions have rated the stock, all giving a "buy" rating - The average target price from institutions over the past 90 days is 3.324 billion yuan [1] Financing and Securities - In the past three months, there has been a net outflow of 1.2098 million yuan in financing, with a decrease in financing balance - There has been a net inflow of 2.9615 million yuan in securities lending, with an increase in the securities lending balance [1]